FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely pulmonology, allergology and laboratory diagnostics, and can be used to control bronchial asthma (BA) treatment. For this purpose, BA is controlled by GINA 2006 criteria in the patients taking a background anti-inflammatory therapy in the form of a combination of inhalation corticosteroids and long-acting β2-agonist. Additionally, peripheral blood CD4+ lymphocytes are counted. If BA values are controlled by GINA 2006 criteria and if the CD4+ cell count is 44 or less, the clinical course of bronchial asthma is considered to be controlled. If the CD4+ cell count is higher than 44, it is uncontrolled.
EFFECT: method enables objectification of clinical effectiveness in BA ensured by supplementary assessment of immunological values significant for BA.
1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DETERMINING BRONCHIAL ASTHMA CONTROL RATIO | 2010 |
|
RU2422827C1 |
| METHOD OF ESTIMATING ANTIASTHMATIC THERAPY EFFICIENCY | 2010 |
|
RU2439570C2 |
| METHOD OF TREATING BRONCHIAL ASTHMA | 2010 |
|
RU2445082C2 |
| METHOD OF ACHIEVING CONTROL OVER BRONCHIAL ASTHMA | 2013 |
|
RU2571894C2 |
| METHOD OF MEDICAL REHABILITATION OF PATIENTS WITH PARTIALLY CONTROLLED MILD BRONCHIAL ASTHMA | 2017 |
|
RU2655543C1 |
| METHOD OF PREDICTING RISK OF UNCONTROLLED BRONCHIAL ASTHMA IN OBESE CHILDREN | 2022 |
|
RU2805825C1 |
| METHOD FOR PREVENTING PARTIALLY CONTROLLED BRONCHIAL ASTHMA CAUSED BY MANGANESE AND VANADIUM EXPOSURE IN CHILDREN AGED 5 AND OLDER | 2014 |
|
RU2546525C1 |
| METHOD OF EVALUATING EFFECTIVENESS BASIC ANTI-INFLAMMATORY THERAPY OF BRONCHIAL ASTHMA IN CHILDREN | 2008 |
|
RU2354970C1 |
| METHOD OF PREVENTING DEVELOPMENT OF UNCONTROLLED BRONCHIAL ASTHMA FORMS INDUCED BY MANGANESE AND VANADIUM IMPACT IN CHILDREN OVER 5 YEARS OLD | 2014 |
|
RU2555341C1 |
| METHOD OF TREATMENT OF BRONCHIAL ASTHMA | 2017 |
|
RU2652752C1 |
